The effects of traditional antirheumatic herbal medicines on immune response cells

Journal of Rheumatology

Volumn 24, Issue 3, 1997, Pages 436-441

  Chang, Deh Ming ^a,b   Chang, Wei Yen ^a,c   Kuo, San Yuan ^a   Chang, Mu Lan ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c Gen Tai Clinic

Author keywords

cytokine; herb; mechanism; phagocytosis

Indexed keywords

CYTOKINE; HERBACEOUS AGENT; PLANT EXTRACT; TETRANDRINE; TRIPTERYGIUM WILFORDII EXTRACT;

ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE RESPONSE; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ALKALOIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODY-PRODUCING CELLS; ANTIRHEUMATIC AGENTS; B-LYMPHOCYTES; BENZYLISOQUINOLINES; DINOPROSTONE; DRUGS, CHINESE HERBAL; HUMANS; IMMUNOGLOBULIN G; NEUTROPHILS; PHAGOCYTOSIS; RHEUMATIC DISEASES;

EID: 0030898022     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Zhang XY, Tsuchiya N, Dohi M, et al: Prolonged survival of MRL-1pr/1pr mice treated with Tripterygium Wilfordii Hook-F. Clin Immunol Immunopathol 1992;62:66-71.
2. Chen ZZ: Active components and preparations of Tripterygium wilfordii Hook f. Chin Hosp Pharm J 1986;6:26-30.
3. Yu D: Clinical observation of 144 cases of rheumatoid arthritis treated with glycosides of Tripterygium wilfordii. J Tradit Clin Med 1983;3:125-9.
4. Wang BX, Yuan ZZ: A tablet of Tripterygium wilfordii in treating lupus erythematosus. Chin J Integrated Tradit West Med 1989;9:407-8.
5. Gu WZ, Banerjee S, Rauch J, Brandwein SR: Suppression of renal disease and arthritis, and prolongation of survival in MRL-1pr mice treated with an extract of Tripterygium Wilfordii Hook F. Arthritis Rheum 1992;35:1381-6.
6. Chen KK, Chen AL: The alkaloids of Han-Fang-Chi. J Biol Chem 1935;109:681-5.
7. Inubushi Y, Masaki Y, Matsumoto S, Takani F: Studies on the alkaloids of Menispermaceous plants. CCXLIX. Total synthesis of optically active natural isotetrandrine, phaeanthine and tetrandrine. J Chem Soc 1969;2:1547-56.
8. Koch AE, Kunkel SL, Strieter RM: Cytokines in rheumatoid arthritis. J Invest Med 1995;43:28-38.
9. Linker-Israeli M: Cytokine abnormalities in human lupus. Clin Immunol Immunopathol 1992;63:10-2.
10. Li Q, Xu Y, Zhon Z, et al: The therapeutic effect of tetrandrine on silicosis. Chin J Tuberc Resp Dis 1981;4:321-8.
11. Engvall E, Jonsson K, Perlmann P: Enzyme-linked immunosorbent assay II quantitative assay of protein antigen, immunoglobulin G, by means of enzyme-labelled antigen and antibody-coated tubes. Biochem Biophys Acta 1971;251:427-34.
12. Jaffe BM, Behrman HR, Parker CW: Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma. J Clin Invest 1973;52:398-405.
13. Hasui M, Hirabayashi Y, Kobayashi Y: Simultaneous measurement by flow cytometry of phagocytosis and hydrogen peroxide production of neutrophils in whole blood. J Immunol Methods 1989;117:53-8.
14. Tao X, Davis LS, Lipsky PE: Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness. Arthritis Rheum 1991;34:1274-81.
15. 2. Yao Hsueh Hsueh Pao-Acta Pharmaceutica Sinica 1991;26:641-5.
16. Ioannoni B, Chalmers AH, Seow WK, McCormack JG, Thong YH: Tetrandrine and transmembrane signal transduction: Effect on phosphoinositide metabolism, calcium flux and protein kinase C translocation in human lymphocytes. Int Arch Allergy Immunol 1989;89:349-54.
17. Seow WK, Ferrante A, Li SY, Thong YH: Suppression of human monocyte interleukin-1 production by the plant alkaloid tetrandrine. Clin Exp Immunol 1989;75:47-51.
18. Teh BS, Ioannoni B, Seow WK, McCormack JG, Thong YH: Suppression by tetrandrine of human platelet aggregation induced by platelet-activating factor and other stimulants. Int Arch Allergy Immunol 1989;88:267-72.
19. Seow WK, Ferrante A, Li SY, Thong YH: Antiphagocytic and antioxidant properties of plant alkaloid tetrandrine. Int Arch Allergy Immunol 1988;85:404-9.
20. Dinarello CA: Interleukin-1. Rev Infect Dis 1984;6:51-63.
21. 2 production by human synovial cells. J Clin Invest 1986;11:645-9.
22. Smith KA: Interleukin-2: A 10 year perspective. In: Smith KA, ed. Interleukin 2. San Diego: Academic Press, 1988.
23. Arend WP, Dayer JM: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305-15.
24. Mosmann TR, Coffman RL: TH1 and TH2 cells: Different patterns of secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
25. Hirano T, Kishimoto T: In: Sporn MB, Roberts AB, eds. Handbook of Experimental Pharmacology Peptide Growth Factors and Their Receptors, vol. 95/1. Berlin: Springer, 1990;633-65.
26. Schroder JM, Mrowietz U, Monta E, Christophers E: Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin-1 activity. J Immunol 1987;139:3474-83.
27. Harris ED Jr: Rheumatoid arthritis: Pathophysiology and implications for therapy. N Engl J Med 1990;332:1277-87.
28. Miyasaka N, Sato K, Goto M, et al: Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients: Possible involvement in joint destruction. Arthritis Rheum 1988;31:480-6.
29. Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factors. Nature 1986;319:516-8.
30. 2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163-8.
31. Helle M, Boeije L, de Groot E, de Vos A, Aarden L: Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: Synovial fluids and sera. J Immunol Methods 1991;138:47-56.
32. Houssiau FA, Devogelaer J-P, Van Damme J, De Deuxchaisnes CN, Van Snick J: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988;31:784-8.
33. Brennen FM, Zachariae COC, Chantry D, et al: Detection of interleukin-8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin-8 mRNA by isolated synovial cells. Eur J Immunol 1990;20:2141-4.
34. Tanaka Y, Saito K, Suzuki H, Eto S, Yamashita U: Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression. J Immunol 1989;143:1584-90.
35. Malave I, Searles RP, Montano J, Williams RC Jr: Production of tumor necrosis factor/cachectin by peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Int Arch Allergy Immunol 1989;89:355-61.
36. Swaak AJ, van Rooyen A, Arden LA: Interleukin-6 and acute phase proteins in the disease course of patients with systemic lupus erythematosus. Rheumatol Int 1989;8:263-8.
37. Hirohata S, Miyamoto T: Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 1990;33:644-9.
38. Huang YP, Perrin LH, Miescher PA, Zubler RH: Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol 1988;141:827-33.
39. Tanaka Y, Saito K, Shirakawa F, et al: Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus. J Immunol 1988;141:3043-9.
40. Chang DM, Baptiste P, Schur PH: The effect of antirheumatic drugs on interleukin-1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes. J Rheumatol 1990;17:1148-57.
41. Chang DM: Mechanisms of methotrexate action in rheumatoid arthritis. Rheumatol Rev 1994;3:43-8.
42. Chang DM, Weinblatt ME, Schur PH: The effects of methotrexate on interleukin-1 in patients with rheumatoid arthritis. J Rheumatol 1992;19:1678-82.
43. Chang DM, Chiao SF: The clinical and immunological effects of cyclosporin A on patients with rheumatoid arthritis. Clin Rheumatol 1995;14:537-43.
44. Hed J, Halden G, Johansson SGO, Larsson P: The use of fluorescence quenching in flow cytometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J Immunol Methods 1987;101:119-25.
45. Matlin SA, Belenguer A, Stacey VE, et al: Male antifertility compounds from Tripterygium Wilfordii Hook f. Contraception 1993;47:387-400.
46. Qian SZ: Tripterygium Wilfordii, a Chinese herb effective in male fertility regulation. Contraception 1987;36:335-45.